BRIEF-France Authorizes Reimbursed Compassionate Use of Agenus’ BOT/BAL for MSS Metastatic Colorectal Cancer

Reuters
Sep 09
BRIEF-France Authorizes Reimbursed Compassionate Use of Agenus’ BOT/BAL for MSS Metastatic Colorectal Cancer

Sept 9 (Reuters) - Agenus Inc AGEN.O:

  • AGENUS: FRANCE GRANTS REIMBURSED COMPASSIONATE ACCESS FOR AGENUS' BOT/BAL IN REFRACTORY MSS METASTATIC COLORECTAL CANCER

Source text: ID:nBw8GztGwa

Further company coverage: AGEN.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10